Shares of Jaguar Health Inc (NASDAQ:JAGX) traded down 18.2% during trading on Monday . The company traded as low as $0.26 and last traded at $0.27. 12,405,623 shares changed hands during trading, an increase of 194% from the average session volume of 4,220,825 shares. The stock had previously closed at $0.33.

Separately, ValuEngine lowered Jaguar Health from a “buy” rating to a “hold” rating in a report on Thursday, January 24th.

The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.31 and a current ratio of 0.46.

TRADEMARK VIOLATION NOTICE: This piece of content was published by Watch List News and is the property of of Watch List News. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States and international copyright law. The correct version of this piece of content can be read at

Jaguar Health Company Profile (NASDAQ:JAGX)

Jaguar Health, Inc, a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc, focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.

See Also: Why Dividend Stocks May Be Right for You

Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with's FREE daily email newsletter.